Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Sarcoma 6Recurrence 3Osteosarcoma 3Rhabdomyosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Leukemia 2Breast Neoplasms 2Vomiting 1Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma, Synovial 1Sarcoma, Myeloid 1Sarcoma, Ewing 1Rhabdoid Tumor 1Neurofibrosarcoma 1Neoplasm Metastasis 1Nausea 1Myeloproliferative Disorders 1Malignant mesenchymal tumor 1Lymphoma, Large B-Cell, Diffuse 1Liposarcoma 1Leukemia, Biphenotypic, Acute 1Leiomyosarcoma 1Hypersensitivity 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Heart Failure 1Fibrosarcoma 1

Interventions

Cyclophosphamide 64fludarabine phosphate 37Peripheral Blood Stem Cell Transplantation 30Cyclosporine 30Radiotherapy 28Mycophenolic Acid 28Filgrastim 28Busulfan 28Whole-Body Irradiation 26Antilymphocyte Serum 24Melphalan 19Etoposide 19Tacrolimus 16Methotrexate 16Cord Blood Stem Cell Transplantation 16Methylprednisolone 15Rituximab 14Thiotepa 10Cytarabine 10Vincristine 8Prednisone 8Doxorubicin 8Carboplatin 7fludarabine 5Sirolimus 5sargramostim 4glofitamab 4aldesleukin 4Therapeutics 4Leucovorin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dendritic Cell Sarcoma, Interdigitating × Dexrazoxane × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡